Oral ciprofloxacin therapy for prosthetic valve endocarditis due to Actinobacillus actinomycetemcomitans.
Babinchak
T J
TJ
Medical College of Pennsylvania, Hahnemann University, Pittsburgh, USA.
D000189:Actinobacillus Infections / Q000188:drug therapy*; D000284:Administration, Oral; D000368:Aged; D016976:Aggregatibacter actinomycetemcomitans / Q000302:isolation & purification; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects* / Q000382:microbiology; D006801:Humans; D016459:Prosthesis-Related Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D002939:Ciprofloxacin